Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: A dose-finding study

M. Reni, S. Cereda, E. Bonetto, M. G. Viganô, P. Passoni, A. Zerbi, G. Balzano, R. Nicoletti, C. Staudacher, V. Di Carlo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: A dose-finding study'. Together they form a unique fingerprint.

Medicine & Life Sciences